'Sun Pharma Shares' - 84 News Result(s)

  • Sun Pharma Rebounds on Value Buying, Stock Jumps Nearly 3%
    Sun Pharma Rebounds on Value Buying, Stock Jumps Nearly 3%

    The shares of Sun Pharma slumped 10 per cent in trades on Tuesday after Japan's Daiichi Sankyo sold its 8.9 per cent stake in India's biggest drugmaker at a discount.

  • Dilip Shanghvi Did Not Buy Daiichi Sankyo's Shares: Sun Pharma
    Dilip Shanghvi Did Not Buy Daiichi Sankyo's Shares: Sun Pharma

    The company was clarifying on speculations that Mr Sanghvi, who holds 9.61 per cent stake in Sun Pharma, had bought shares when Daiichi Sankyo exited from the Indian firm.

  • Wipro, Yes Bank, Natco Pharma in Focus Today
    Wipro, Yes Bank, Natco Pharma in Focus Today

    The Nifty is likely to open lower on Wednesday tracking lacklustre cues from the global markets. Foreign investors bought shares worth Rs 17,489 crore on Tuesday, but this amount includes purchases of Sun Pharma shares sold by Japan's Daiichi Sankyo,...

  • NSE Sees Record High at Rs 41,165 Cr in Cash Market Segment
    NSE Sees Record High at Rs 41,165 Cr in Cash Market Segment

    Daiichi which had forayed into the Indian pharmaceutical market by buying a majority stake in Ranbaxy Laboratories in 2008 for Rs 22,000 crore, today sold over 21 crore shares in Sun Pharma.

  • Sensex, Nifty Flat; Sun Pharma, HCL Tech Shares Slump
    Sensex, Nifty Flat; Sun Pharma, HCL Tech Shares Slump

    Shares of Sun Pharmaceutical Industries slumped over 10 per cent to hit intraday low of Rs 938 after Daichi Sankyo planned to sell 8.9 per cent stake in Sun Pharma.

  • Sun Pharma Slumps Over 10% as Daiichi Exits
    Sun Pharma Slumps Over 10% as Daiichi Exits

    Japan's Daiichi Sankyo Company Ltd is selling shares worth up to $3.6 billion in Sun Pharmaceutical Industries.

  • Pharma Stocks Fall on Bank of America Merrill Lynch Downgrade
    Pharma Stocks Fall on Bank of America Merrill Lynch Downgrade

    Shares of Sun Pharma fell nearly 4 per cent to hit low of Rs 1,116 after Bank of America Merill Lynch downgraded the stock to 'underperform' from 'buy'.

  • Sensex Edges Down in Cautious Trade; Sun Pharma Rises
    Sensex Edges Down in Cautious Trade; Sun Pharma Rises

    Shares have retreated since hitting record highs early this month, as analysts warned about waning momentum and low trading volumes ahead of the end of the fiscal year at the end of March.

  • Sun Pharma Gets RBI Nod for Transfer of Ranbaxy Overseas Investments
    Sun Pharma Gets RBI Nod for Transfer of Ranbaxy Overseas Investments

    Sun Pharmaceutical Industries has received approval from the Reserve Bank of India (RBI) for transfer of overseas investments of Ranbaxy to it and issue its shares to the non-resident shareholders of the latter as part of the $4-billion merger deal b...

  • Sun Pharma, Ranbaxy, JSPL in Focus Today
    Sun Pharma, Ranbaxy, JSPL in Focus Today

    The Nifty opened flat on Tuesday. However, sentiment is likely to be positive as both foreign and domestic investors turned net buyers of Indian equities on Monday. Foreign investors bought shares worth Rs 417 crore while, domestic investors were net...

  • Why SPARC Shares Surged Over 40% in March
    Why SPARC Shares Surged Over 40% in March

    The trading volumes in the month so far has been very high; on Monday as many as 6 million shares of SPARC changed hands on the BSE.

  • Dilip Shanghvi Overtakes Mukesh Ambani as Richest Indian: Forbes
    Dilip Shanghvi Overtakes Mukesh Ambani as Richest Indian: Forbes

    Pharmaceuticals tycoon Dilip Shanghvi has surpassed Mukesh Ambani as the world's richest Indian with a net worth of $21.5 billion (Rs 1.33 lakh crore at 1 dollar = 62 rupees) - within two days of the Reliance Industries chief being ranked India's wea...

  • US Regulator Raises Concerns on Waluj Plant: Wockhardt
    US Regulator Raises Concerns on Waluj Plant: Wockhardt

    Shares in Wockhardt Ltd fell as much as 5.3 per cent on Thursday after the drug maker said the US Food and Drug Administration (FDA) had raised fresh concerns about a plant already banned from exporting to the United States over quality issues.

  • Suzlon Soars 20% as Dilip Shanghvi Buys Stake
    Suzlon Soars 20% as Dilip Shanghvi Buys Stake

    Shares in Suzlon Energy jumped over 18 per cent on Monday after the debt-laden turbine maker got an investor in the form of Sun Pharma's billionaire promoter Dilip Shanghvi.

  • Sun Pharma Founder's Wife Gets Rs 280 Crore Shares in Gift
    Sun Pharma Founder's Wife Gets Rs 280 Crore Shares in Gift

    Sun Pharma founder Dilip Shanghvi's mother Kumud has gifted nearly 31 lakh shares in the drugmaker to her daughter-in-law Vibha, according to a regulatory filing on the Bombay Stock Exchange. The transfer took place on January 30 and is valued at Rs ...

  • Sun Pharma, Ranbaxy Hit 52-Week Highs on Merger Nod
    Sun Pharma, Ranbaxy Hit 52-Week Highs on Merger Nod

    Shares of Sun Pharma jumped as much as 3 per cent to a hit new 52-week high of Rs 943. Ranbaxy also jumped as much as 3.6 per cent to hit its new 52-week high of Rs 728.

  • Ranbaxy, TVS Motor, SRF in Focus Today
    Ranbaxy, TVS Motor, SRF in Focus Today

    The Nifty opened higher on Friday as indicated by futures trade on Singapore Stock Exchange. Both foreign and domestic investors turned net buyers of Indian equities on Thursday but with low intensity. Foreign investors bought shares worth Rs 18 cror...

  • Sensex Turns Negative, Nifty Falls Below 8,300
    Sensex Turns Negative, Nifty Falls Below 8,300

    Shares in oil explorers continued to drag the benchmark indices further. Cairn India fell nearly 3 per cent, while ONGC was down over 2 per cent amid margin concerns on account of falling crude oil prices. GAIL India slumped nearly 4 per cent to be t...

  • Sensex Falls Over 200 Points, Metal Stocks Drag
    Sensex Falls Over 200 Points, Metal Stocks Drag

    Market breadth turned negative as 920 stocks out of the 2,751 shares traded on BSE advanced and 1,738 stocks declined.

  • Sun Pharma, Ranbaxy, OnMobile Global in Focus Today
    Sun Pharma, Ranbaxy, OnMobile Global in Focus Today

    The Nifty opened lower on Tuesday tracking a sell-off in the global market. However Brent crude price, which fell to a fresh five-year low, is likely to keep sentiments positive today. Foreign investors remained net buyers to the tune of Rs 4,985 cro...

Advertisement

Advertisement

Market Data provided by © Accord Fintech.
© Copyright NDTV Convergence Limited 2015. All rights reserved.